Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2021-10-12 00:00:00 ET · period of report 2021-10-12 · accession 0001179110-21-009380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-12 | 2021-10-12 | HALO | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $13.10 | +8,050 | 156.8K | +5% | +$105.5K |
| D | 2021-10-12 | 2021-10-12 | HALO | LaBarre Michael J. | SVP, Chief Technical Off | M - OptEx | $0.00 | -8,050 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-12 | M | A | 8,050 | $13.10 | 156,846 | D | — | — | |
| 2 | Derivative | Option to Purchase Common Stock | 2021-10-12 | M | D | 8,050 | $0.00 | 0 | D | $13.10 · — to 2024-02-06 | 8,050 Common Stock | (F1) This option was granted on February 6, 2014 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. |